Prostate specific antigen after gonadal androgen withdrawal and deferred flutamide treatment

The Journal of Urology
J E FowlerT P Feliz

Abstract

We assess the impact of deferred flutamide treatment on the serum prostate specific antigen (PSA) level in patients with localized or metastatic cancer. The study included 45 patients with localized cancer and 50 with metastatic cancer with an increasing (87) or stable (8) PSA level after gonadal androgen withdrawal. Of 40 evaluable patients with localized cancer and 50 with metastatic cancer 32 (80%) and 27 (54%), respectively, had a PSA decrease of 50% or more of baseline during flutamide treatment (p = 0.014). Among patients with localized cancer actuarial analysis of freedom from PSA elevation during flutamide treatment favored those with a 50% or greater PSA decrease (p = 0.006) but in patients with metastatic cancer the analysis revealed no significant difference. The relative density of tumor cells that are dependent on adrenal androgen after gonadal androgen withdrawal may be greater in patients with localized cancer and deferred flutamide treatment may enhance cancer control in those with localized disease.

References

Dec 1, 1990·The Journal of Urology·S D FossåE Paus
Aug 17, 1989·The New England Journal of Medicine·E D CrawfordP J Goodman
May 1, 1980·The Journal of Urology·J F GaetaG P Murphy
Apr 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K KellyS D Fossa
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H I Scher, W K Kelly

❮ Previous
Next ❯

Citations

Oct 21, 2005·Der Urologe. Ausg. A·A Heidenreich, C H Ohlmann
Nov 29, 2005·Der Urologe. Ausg. A·A Heidenreich
Apr 28, 2012·Current Treatment Options in Oncology·Won Kim, Charles J Ryan
Apr 26, 2005·Current Oncology Reports·Charles J Ryan, Eric J Small
Jun 27, 2002·Current Urology Reports·K A Harris, E J Small
Feb 9, 2000·Radiologic Clinics of North America·E J Small, D M Reese
Jun 6, 2003·Cancer Treatment Reviews·Cynthia L MartelPrimo N Lara
Mar 23, 2012·Japanese Journal of Clinical Oncology·Norihito SogaYoshiki Sugimura
Jun 9, 2005·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Isao KiriyamaTaiji Nishimura
Jun 23, 2006·Clinical Journal of Oncology Nursing·Christine Liebertz, Patricia Fox
Feb 28, 2001·Expert Opinion on Investigational Drugs·K A Harris, E J Small
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J SmallNicholas J Vogelzang
May 24, 2017·Expert Review of Anticancer Therapy·Archana Anantharaman, Eric J Small
Jun 11, 1999·The Urologic Clinics of North America·D M Reese, E J Small
Jan 13, 2006·The Journal of Urology·John S LamArie S Belldegrun
Apr 23, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Hiroyoshi SuzukiAtsushi Mizokami
Apr 8, 2006·American Journal of Clinical Oncology·Guru Sonpavde, Thomas E Hutson
Apr 14, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Norihito SogaYoshiki Sugimura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.